Skip to content
Advertisement

PathAI develops AI models for pathology, trained on a dataset of more than 15 million expert-annotated pathology slide annotations, and operates the AISight image management system alongside a network of partner pathology labs. Roche has agreed to acquire PathAI for up to $1.05B in a deal announced in May 2026 that had not yet closed as of this writing.

Image
Advertisement